Given the result that IRF4 is not expressed in polymorphonuclear cells, it was not surprising that the deletion of IRF4 in Ly6G+ cells in vivo did not influence tumor growth, overall survival or MDSC cell frequency. The gene discussed is IRF4; the disease is neoplasm.